Different fatty acid metabolism effects of (−)-Epigallocatechin-3-Gallate and C75 in Adenocarcinoma lung cancer

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Epigallocatechin Gallate Suppresses Lung Cancer Cell Growth through Ras-GTPase-Activating Protein SH3 Domain-Binding Protein 1

(2010) J. H. Shim et al.   Cancer Prevention Research

The SDF-1 /CXCR4 axis induces the expression of fatty acid synthase via sterol regulatory element-binding protein-1 activation in cancer cells

(2010) K. Kim et al.   CARCINOGENESIS

Pro-oxidative activities and dose–response relationship of (−)-epigallocatechin-3-gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro

(2010) Guang-Xun Li et al.   CARCINOGENESIS

Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells

(2010) A. Vazquez-Martin et al.   CELL PROLIFERATION

Osthole Suppresses Fatty Acid Synthase Expression in HER2-Overexpressing Breast Cancer Cells through Modulating Akt/mTOR Pathway

(2010) Victor Chia-Hsiang Lin et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells

(2009) Thomas W. Grunt et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity

(2009) T. Puig et al.   CLINICAL CANCER RESEARCH

EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells

(2009) Chi-Hung Huang et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549

(2009) Rieko Yamauchi et al.   TOXICOLOGY IN VITRO